Market News AIOpen the app

AUPH stock news · Aurinia Pharmaceuticals Inc.

Stories about Aurinia Pharmaceuticals Inc. (AUPH) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for AUPH

Follow Aurinia Pharmaceuticals Inc. (AUPH) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for AUPH
Free on the App Store and Google Play, or on the web.
  1. Oct 30, 2026, 8:26 AM ET · Market

    Aurinia Pharmaceuticals shared its financial results and business update for the third quarter of 2026.

    Neutral

    Aurinia filed a report saying it issued quarterly results, but the provided filing has no sales or profit figures. It does not change the outlook.

  2. Aug 20, 2026, 9:54 AM ET · Trial

    Aurinia Pharmaceuticals and Teva resolve patent conflict regarding kidney disease medication.

    Good for AUPH

    Aurinia Pharmaceuticals has settled a patent dispute with Teva, which validates its patents and delays Teva's entry into the market with a generic version of voclosporin. This settlement is expected to bolster Aurinia's stock performance while posing challenges for Teva's competitive positioning in the kidney disease treatment market.